Neupro®
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Idiopathic Restless Legs Syndrome
Conditions
Idiopathic Restless Legs Syndrome
Trial Timeline
May 1, 2010 → Jul 1, 2011
NCT ID
NCT01113710About Neupro®
Neupro® is a pre-clinical stage product being developed by UCB for Idiopathic Restless Legs Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT01113710. Target conditions include Idiopathic Restless Legs Syndrome.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01330290 | Pre-clinical | Completed |
| NCT01113710 | Pre-clinical | Completed |
Competing Products
20 competing products in Idiopathic Restless Legs Syndrome